Brrrrr, and greetings to all as we begin a New Year!
The Board of Directors started 2024 with an in-person meeting and much discussion regarding critical societal programs and issues. Topping the list is the coming annual meeting in Chicago (May 2-5). The program is shaping up quite nicely — a record number of abstracts have been submitted, the call for “Late-Breaking Abstracts” has recently gone out, and registration will open soon. Other major items of discussion included addressing our workforce and streamlining our annual grant review process. We met with our Mission Alliance Partners to identify concerns of mutual interest. A rewarding sidelight of the meeting was an “ice-breaker” event in which Board members worked in teams with MAP partners on a project aiding the South Lakes High School Pantry, who serve the local community. As 1 in 7 children in Virginia go to sleep every night insufficiently fed, our donation of nearly 900 cans of food items was greatly appreciated.
This month I would like to spotlight the “MOC and QI Committee” under the leadership of Justin Indyk.
Justin’s team has been working on a new QI Toolkit with top takeaways and pearls for aspiring QI researchers. The toolkit will provide clinicians with step-by-step guidance on how to conduct QI projects within their institutions covering these areas:
- QI Learning Resources, tutorials, and tools
- How to claim MOC Part 4 credit (as easily as possible!).
- Publishing your QI work
Justin also reports that the MOC Part 2 Session is returning to the annual meeting after several years away (tentatively scheduled for Sunday 5/5/23 1-3pm). An article list is in the making. Many thanks Justin for the hard work by you and your committee for these important contributions.
On a final note, I wish to call attention to the new grant review framework being rolled out by NIH beginning in January 2025. This will apply to project grants initially and is eventually likely to incorporate K grants. More at:
Tom Carpenter, MD
2024 Annual Meeting registration is opening February 1! Are your dues current
PES membership is on a calendar year so likely time to renew! Accessing your membership record and checking your membership status is easy! Do not delay.
Visit the website and check your membership status by using your PES membership credentials and logging into this link: https://pedsendo.app.neoncrm.com/login.jsp
Click the button in the top right corner labeled “Renew”. This will take you to the renewal page. Please also review your complete record and make sure the demographical information is filled out and current. This information helps us tailor program and services that best meet your needs and preferences.
For a receipt, click “Membership” on the left-hand side. Then select the membership charge you want a receipt for. Finally, click the “Download” button to download that receipt. Then you should be all set!
2024 Annual Meeting registration opens February 1!
Please visit our 2024 annual meeting webpage for all the information you need to register and attend the annual meeting. Bookmark the page, and visit often, as we will be making updates as logistics become firm. PES Annual Meeting – Pediatric Endocrine Society (pedsendo.org)
Late breaking abstracts being accepted:
The Program Committee is now accepting a limited number of abstracts detailing noteworthy impactful studies for which data analysis was incomplete at the time of the December abstract submission deadline. You may submit a late-breaking abstract regarding your research only if data analysis is now complete.
Please note: Case reports will not be accepted.
Deadline: Monday, February 5, 2024 @ 11:59 PM ET
Please click here to find instructions on how to prepare and submit your abstract.
In Memoriam: Pierre Claude Sizonenko, (19 April, 1932 – 13 Feb, 2023)
In Memoriam: Arlan Rosenbloom, MD
In Memoriam: George E. Bacon. April 18, 1932 – December 27, 2023
From the D&T – Statement on use of compounded semaglutide and other GLP-1 receptor agonists
The use of glucagon-like-peptide-1 (GLP-1) receptor agonists for the treatment of obesity has increased significantly over the past year. Due to high demands and limited supply, patients and clinicians are turning to compounding pharmacies. Click here to read more: https://pedsendo.org/drug-shortages/statement-on-use-of-compounded-semaglutide-and-other-glp-1-receptor-agonists/
EDI Spotlight – February is Black History Month: Celebrating the Legacy of James McCune Smith, MD
PES, EDI Task force Podcast Club: titled “Remembering and Unremembering, from Kigali to Nashville” from the Code Switch series by NPR
Feb 13, 2024 08:00 PM Eastern
The EDI task force is excited to announce our upcoming Podcast Club on February 13, 2024, at 08:00 PM. For this session, we’ll be diving into an intriguing episode titled “Remembering and Unremembering, from Kigali to Nashville” from the Code Switch series by NPR. This episode promises to offer a compelling narrative, blending both racial and immigration perspectives. Our gathering will be a great opportunity to share thoughts, and reflections, and engage in a meaningful dialogue sparked by this episode. Please ensure you’ve listened to the episode before the meeting so we can have a rich and informed discussion. You can find the episode below: Remembering and unremembering, from Kigali to Nashville: Code Switch: NPR
Looking forward to an evening of engaging conversations and shared experiences. Don’t forget to bring your curiosity and insights.
Fellow Spotlight – Juwairiyyah Siddiqui, MD
Historic Tidbit: Arnold Adolph Berthold (1803-1861) Testis Transplantation and the Regain of Male Sexual Characteristics and Behaviors
Submitted by Alan Rogol
From the NIH: 2023: A Year in Review
By Mike Lauer
We started 2023 with implementing the NIH Data Management and Sharing policy. The year was capped off with Dr. Monica Bertagnolli beginning as the next NIH Director. I virtually sat down with Dr. David Kosub, from our communications group, again this year to look back and share thoughts on what is to come for 2024. Read more: 2023: A Year in Review – NIH Extramural Nexus